These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 18421906)

  • 1. [The interconnections of molecular mechanisms of hormone actions and their role in pathogenesis of obesity, insulin resistance, and diabetes mellitus].
    Pankov IuA; Chekhranova MK; Karpova SK
    Vestn Ross Akad Med Nauk; 2008; (3):28-36. PubMed ID: 18421906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response of melanocortin-4 receptor-deficient mice to anorectic and orexigenic peptides.
    Marsh DJ; Hollopeter G; Huszar D; Laufer R; Yagaloff KA; Fisher SL; Burn P; Palmiter RD
    Nat Genet; 1999 Jan; 21(1):119-22. PubMed ID: 9916804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-obese and obese agouti mice are sensitive to the anorectic effects of peptide YY(3-36) but resistant to ghrelin.
    Martin NM; Small CJ; Sajedi A; Patterson M; Ghatei MA; Bloom SR
    Int J Obes Relat Metab Disord; 2004 Jul; 28(7):886-93. PubMed ID: 15148507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of methamphetamine on expression of neuropeptide Y mRNA in hypothalamus and on serum leptin and ghrelin concentrations in ad libitum-fed and schedule-fed rats.
    Crowley WR; Ramoz G; Keefe KA; Torto R; Kalra SP; Hanson GR
    Neuroscience; 2005; 132(1):167-73. PubMed ID: 15780475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of in vivo and in vitro administration of ghrelin, leptin and neuropeptide mediators on pulsatile gonadotrophin-releasing hormone secretion from male rat hypothalamus before and after puberty.
    Lebrethon MC; Aganina A; Fournier M; Gérard A; Parent AS; Bourguignon JP
    J Neuroendocrinol; 2007 Mar; 19(3):181-8. PubMed ID: 17280591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma and hypothalamic peptide-hormone levels regulating somatotroph function and energy balance in fed and fasted states: a comparative study in four strains of rats.
    Kappeler L; Zizzari P; Grouselle D; Epelbaum J; Bluet-Pajot MT
    J Neuroendocrinol; 2004 Dec; 16(12):980-8. PubMed ID: 15667453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain somatic cross-talk: ghrelin, leptin and ultimate challengers of obesity.
    Popovic V; Duntas LH
    Nutr Neurosci; 2005 Feb; 8(1):1-5. PubMed ID: 15909762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuro-hormonal control of food intake: basic mechanisms and clinical implications.
    Konturek PC; Konturek JW; Cześnikiewicz-Guzik M; Brzozowski T; Sito E; Konturek SJ
    J Physiol Pharmacol; 2005 Dec; 56 Suppl 6():5-25. PubMed ID: 16340035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropeptide Y and alpha-melanocyte-stimulating hormone: interaction in obesity and possible role in the development of hypertension.
    Baltatzi M; Hatzitolios A; Tziomalos K; Iliadis F; Zamboulis Ch
    Int J Clin Pract; 2008 Sep; 62(9):1432-40. PubMed ID: 18793378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adipose tissue as an endocrine organ.
    Ahima RS
    Obesity (Silver Spring); 2006 Aug; 14 Suppl 5():242S-249S. PubMed ID: 17021375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [From obesity to diabetes].
    Stöckli R; Keller U
    Ther Umsch; 2002 Aug; 59(8):388-92. PubMed ID: 12235730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The role of the fat tissue and its hormones in the mechanisms of insulin resistance and the development of type 2 diabetes mellitus].
    Klebanova EM; Balabolkin MI; Kreminskaia VM
    Klin Med (Mosk); 2007; 85(7):20-7. PubMed ID: 17882804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current and investigational antiobesity agents and obesity therapeutic treatment targets.
    Bays HE
    Obes Res; 2004 Aug; 12(8):1197-211. PubMed ID: 15340100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroendocrine control of food intake.
    Valassi E; Scacchi M; Cavagnini F
    Nutr Metab Cardiovasc Dis; 2008 Feb; 18(2):158-68. PubMed ID: 18061414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adipokines that link obesity and diabetes to the hypothalamus.
    Ahima RS; Qi Y; Singhal NS
    Prog Brain Res; 2006; 153():155-74. PubMed ID: 16876574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physiological and pathophysiological roles of adiponectin and adiponectin receptors in the integrated regulation of metabolic and cardiovascular diseases.
    Yamauchi T; Kadowaki T
    Int J Obes (Lond); 2008 Dec; 32 Suppl 7():S13-8. PubMed ID: 19136982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
    Højlund K
    Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obesity in MENX Rats Is Accompanied by High Circulating Levels of Ghrelin and Improved Insulin Sensitivity.
    Wiedemann T; Bielohuby M; Müller TD; Bidlingmaier M; Pellegata NS
    Diabetes; 2016 Feb; 65(2):406-20. PubMed ID: 26512025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adiponectin and its role in the obesity-induced insulin resistance and related complications.
    Haluzík M; Parízková J; Haluzík MM
    Physiol Res; 2004; 53(2):123-9. PubMed ID: 15046547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Insulin resistance, role of leptin and leptin receptor].
    Shintani M; Ogawa Y; Nakao K
    Nihon Rinsho; 2000 Feb; 58(2):327-32. PubMed ID: 10707553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.